SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

USFDA issues warning letter to Jubilant Life Sciences’ manufacturing facility in Canada

27 Feb 2013 Evaluate

Jubilant Life Sciences has been issued a warning letter (WL) for one of its manufacturing facility, Jubilant HollisterStier General Partnership (JHS) located at Kirkland, Quebec in Canada. The company has received WL from US Food and Drug Administration (USFDA) identifying significant violations of current Good Manufacturing Practices (cGMP) Regulations.

As required by USFDA, JHS will respond to this WL on or before March 15, 2013. The response will provide details as to what corrective action has already been completed, as well as, additional detail as to how the facility will prevent the reoccurrence of the items found to be objectionable to the USFDA.

USFDA specified in the WL that until all corrections have been completed and that they have confirmed correction of the violations and firm compliance to cGMPs, USFDA may withhold approval of new applications or supplements listing JHS as the drug product manufacturer.

The company expects that the on-going manufacturing, distribution and sale of products will not be affected by this WL. Besides, JHS is committed to implementing the necessary corrective actions required to address the USFDA concerns, and will work closely with the USFDA to bring resolution to this matter.

Jubilant Pharmova Share Price

911.60 6.55 (0.72%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×